Naresh KUMAR

Person

  • Hawthorne, NY, US

Patents Grantslast 30 patents

  • Information Patent Grant

    Antibody targeting CD22 and CD79B

    • Patent number 12,180,278
    • Issue date Dec 31, 2024
    • Janssen Biotech, Inc.
    • Kyle J. Bednar
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    CD226 agonist antibodies

    • Patent number 11,440,959
    • Issue date Sep 13, 2022
    • Eli Lilly and Company
    • Naresh Kumar
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

  • Information Patent Application

    ANTIBODY TARGETING CD22 AND CD79B

    • Publication number 20250066474
    • Publication date Feb 27, 2025
    • JANSSEN BIOTECH, INC.
    • Kyle J. Bednar
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    ANTIBODY TARGETING CD22 AND CD79B

    • Publication number 20220306738
    • Publication date Sep 29, 2022
    • JANSSEN BIOTECH, INC.
    • Kyle J. Bednar
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    TIGIT AND PD-1/TIGIT-BINDING MOLECULES

    • Publication number 20220227860
    • Publication date Jul 21, 2022
    • Eli Lilly and Company
    • Yiqing FENG
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    CD226 AGONIST ANTIBODIES

    • Publication number 20210363241
    • Publication date Nov 25, 2021
    • Eli Lilly and Company
    • Naresh KUMAR
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE